Bone-density testing interval and transition to osteoporosis in patients with rheumatoid arthritis View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2016-08-10

AUTHORS

J. Hwang, E.-K. Lee, J. K. Ahn, H.-S. Cha, E.-M. Koh, J. Lee

ABSTRACT

The study aims to evaluate the rate of transition to osteoporosis in 360 RA patients and estimate the rescreening intervals of bone mineral density (BMD) testing. Osteoporosis was newly developed in 24.8 % during mean follow-up of 7.4 years. The estimated time of a BMD testing interval was dependent on the baseline T-score in RA patients.IntroductionAlthough BMD testing is routinely performed in RA patients, the interval between BMD tests has not been determined.MethodsWe retrospectively recruited 360 consecutive female patients with RA, who underwent repeated BMD testing, with a mean age of 53.7 ± 10.2 years and a mean follow-up duration of 7.4 ± 5.0 years. We stratified the study participants into five groups based on their baseline T-score range. The testing interval was defined as the estimated time for 10 % of patients in each subgroup to transition to osteoporosis. Competing-risk analyses were performed with sensitivity analysis by menopausal status and risk factors for transition to osteoporosis.ResultsAt baseline, 15 % of screened patients had osteoporosis, and during follow-up, that proportion increased to 24.8 %. The estimated BMD testing interval for 10 % of patients to develop osteoporosis was 9.6 years for those with normal BMD, 7.6 years for those with mild osteopenia, 4.7 years for those with moderate osteopenia, and 2.1 years for those with severe osteopenia. No significant risk factor for transition to osteoporosis was identified in this cohort.ConclusionsOur data indicate that osteoporosis will develop in less than 10 % of female RA patients during rescreening intervals of approximately 9 years for those with normal bone density at baseline, 7 years for those with mild osteopenia, 4 years for those with moderate osteopenia, and 2 years for those with severe osteopenia at baseline. BMD interval in RA patients could be adjusted according to their baseline BMD T-scores. More... »

PAGES

231-237

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00198-016-3703-7

DOI

http://dx.doi.org/10.1007/s00198-016-3703-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1022991236

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27509834


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Absorptiometry, Photon", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Arthritis, Rheumatoid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bone Density", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bone Diseases, Metabolic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Progression", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mass Screening", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Osteoporosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Assessment", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, National Police Hospital, Seoul, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.415671.0", 
          "name": [
            "Department of Internal Medicine, National Police Hospital, Seoul, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hwang", 
        "givenName": "J.", 
        "id": "sg:person.01166345411.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01166345411.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Pharmaceutical Policy & Outcomes Research, Sungkyunkwan University School of Pharmacy, Suwon, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.264381.a", 
          "name": [
            "Pharmaceutical Policy & Outcomes Research, Sungkyunkwan University School of Pharmacy, Suwon, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "E.-K.", 
        "id": "sg:person.01143324620.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143324620.76"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.264381.a", 
          "name": [
            "Department of Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ahn", 
        "givenName": "J. K.", 
        "id": "sg:person.0743465725.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743465725.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, 06351, Seoul, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.414964.a", 
          "name": [
            "Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, 06351, Seoul, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cha", 
        "givenName": "H.-S.", 
        "id": "sg:person.01045430556.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01045430556.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, 06351, Seoul, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.414964.a", 
          "name": [
            "Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, 06351, Seoul, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Koh", 
        "givenName": "E.-M.", 
        "id": "sg:person.01312643345.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01312643345.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, 06351, Seoul, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.414964.a", 
          "name": [
            "Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, 06351, Seoul, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "J.", 
        "id": "sg:person.011106215224.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011106215224.30"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s10067-011-1762-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049467027", 
          "https://doi.org/10.1007/s10067-011-1762-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s001980070080", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005068152", 
          "https://doi.org/10.1007/s001980070080"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/ar2961", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028976451", 
          "https://doi.org/10.1186/ar2961"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00296-008-0804-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022170133", 
          "https://doi.org/10.1007/s00296-008-0804-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s007740050038", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007538058", 
          "https://doi.org/10.1007/s007740050038"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00198-014-2794-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038754393", 
          "https://doi.org/10.1007/s00198-014-2794-2"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-08-10", 
    "datePublishedReg": "2016-08-10", 
    "description": "The study aims to evaluate the rate of transition to osteoporosis in 360 RA patients and estimate the rescreening intervals of bone mineral density (BMD) testing. Osteoporosis was newly developed in 24.8\u00a0% during mean follow-up of 7.4\u00a0years. The estimated time of a BMD testing interval was dependent on the baseline T-score in RA patients.IntroductionAlthough BMD testing is routinely performed in RA patients, the interval between BMD tests has not been determined.MethodsWe retrospectively recruited 360 consecutive female patients with RA, who underwent repeated BMD testing, with a mean age of 53.7\u2009\u00b1\u200910.2\u00a0years and a mean follow-up duration of 7.4\u2009\u00b1\u20095.0\u00a0years. We stratified the study participants into five groups based on their baseline T-score range. The testing interval was defined as the estimated time for 10\u00a0% of patients in each subgroup to transition to osteoporosis. Competing-risk analyses were performed with sensitivity analysis by menopausal status and risk factors for transition to osteoporosis.ResultsAt baseline, 15\u00a0% of screened patients had osteoporosis, and during follow-up, that proportion increased to 24.8\u00a0%. The estimated BMD testing interval for 10\u00a0% of patients to develop osteoporosis was 9.6\u00a0years for those with normal BMD, 7.6\u00a0years for those with mild osteopenia, 4.7\u00a0years for those with moderate osteopenia, and 2.1\u00a0years for those with severe osteopenia. No significant risk factor for transition to osteoporosis was identified in this cohort.ConclusionsOur data indicate that osteoporosis will develop in less than 10\u00a0% of female RA patients during rescreening intervals of approximately 9\u00a0years for those with normal bone density at baseline, 7\u00a0years for those with mild osteopenia, 4\u00a0years for those with moderate osteopenia, and 2\u00a0years for those with severe osteopenia at baseline. BMD interval in RA patients could be adjusted according to their baseline BMD T-scores.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00198-016-3703-7", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1100834", 
        "issn": [
          "0937-941X", 
          "1433-2965"
        ], 
        "name": "Osteoporosis International", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "28"
      }
    ], 
    "keywords": [
      "BMD testing interval", 
      "RA patients", 
      "moderate osteopenia", 
      "BMD testing", 
      "mild osteopenia", 
      "risk factors", 
      "severe osteopenia", 
      "testing intervals", 
      "bone mineral density testing", 
      "competing-risk analysis", 
      "baseline BMD T", 
      "female RA patients", 
      "consecutive female patients", 
      "significant risk factors", 
      "normal bone density", 
      "ResultsAt baseline", 
      "normal BMD", 
      "menopausal status", 
      "BMD T", 
      "female patients", 
      "ConclusionsOur data", 
      "rheumatoid arthritis", 
      "mean age", 
      "BMD test", 
      "bone density", 
      "osteopenia", 
      "density testing", 
      "osteoporosis", 
      "patients", 
      "study participants", 
      "baseline", 
      "score range", 
      "scores", 
      "years", 
      "intervals", 
      "arthritis", 
      "BMD", 
      "MethodsWe", 
      "cohort", 
      "testing", 
      "rate of transition", 
      "age", 
      "factors", 
      "subgroups", 
      "duration", 
      "status", 
      "participants", 
      "group", 
      "proportion", 
      "RA", 
      "study", 
      "sensitivity analysis", 
      "time", 
      "rate", 
      "test", 
      "analysis", 
      "data", 
      "range", 
      "density", 
      "transition", 
      "mineral density (BMD) testing", 
      "IntroductionAlthough BMD testing", 
      "estimated BMD testing interval", 
      "BMD interval", 
      "Bone-density testing interval"
    ], 
    "name": "Bone-density testing interval and transition to osteoporosis in patients with rheumatoid arthritis", 
    "pagination": "231-237", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1022991236"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00198-016-3703-7"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27509834"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00198-016-3703-7", 
      "https://app.dimensions.ai/details/publication/pub.1022991236"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-11-01T18:28", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/article/article_700.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00198-016-3703-7"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00198-016-3703-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00198-016-3703-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00198-016-3703-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00198-016-3703-7'


 

This table displays all metadata directly associated to this object as RDF triples.

254 TRIPLES      22 PREDICATES      112 URIs      98 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00198-016-3703-7 schema:about N0aac0bd0e70049dd96404c6f2b4bacda
2 N1ab64cd21f9c4154b920096bb01dcb4d
3 N1df2c80780394828a509479dc0a67118
4 N41d7469c50814b62ae5a7f8da5f7510c
5 N4b038adc172f42ebb4f8c1e3c593e60c
6 N4d3c558884cd40fe9332e6919d016cec
7 N85c313263c7f4b08820e8b314d2404aa
8 N86bd08aee8fa446d97829d1ab97dfe20
9 Nb41eb2944e874d0e9f5a23a83ee90769
10 Nc52a8a37cdad4f22be1ff7126d761105
11 Nddb690d4a60f41f4a471e5b81c4243f1
12 Ne69abc77a6fd44558b4c53e22abca7da
13 Nf6205c25e8c34e229d3c7d4cebb47049
14 Nf8bd5532e60f400a80863f70b46f75c7
15 Nfacbf04761184e979ec83817a7f56369
16 anzsrc-for:11
17 anzsrc-for:1103
18 schema:author Nee16bf11db784314ba9509cefb339047
19 schema:citation sg:pub.10.1007/s00198-014-2794-2
20 sg:pub.10.1007/s001980070080
21 sg:pub.10.1007/s00296-008-0804-4
22 sg:pub.10.1007/s007740050038
23 sg:pub.10.1007/s10067-011-1762-x
24 sg:pub.10.1186/ar2961
25 schema:datePublished 2016-08-10
26 schema:datePublishedReg 2016-08-10
27 schema:description The study aims to evaluate the rate of transition to osteoporosis in 360 RA patients and estimate the rescreening intervals of bone mineral density (BMD) testing. Osteoporosis was newly developed in 24.8 % during mean follow-up of 7.4 years. The estimated time of a BMD testing interval was dependent on the baseline T-score in RA patients.IntroductionAlthough BMD testing is routinely performed in RA patients, the interval between BMD tests has not been determined.MethodsWe retrospectively recruited 360 consecutive female patients with RA, who underwent repeated BMD testing, with a mean age of 53.7 ± 10.2 years and a mean follow-up duration of 7.4 ± 5.0 years. We stratified the study participants into five groups based on their baseline T-score range. The testing interval was defined as the estimated time for 10 % of patients in each subgroup to transition to osteoporosis. Competing-risk analyses were performed with sensitivity analysis by menopausal status and risk factors for transition to osteoporosis.ResultsAt baseline, 15 % of screened patients had osteoporosis, and during follow-up, that proportion increased to 24.8 %. The estimated BMD testing interval for 10 % of patients to develop osteoporosis was 9.6 years for those with normal BMD, 7.6 years for those with mild osteopenia, 4.7 years for those with moderate osteopenia, and 2.1 years for those with severe osteopenia. No significant risk factor for transition to osteoporosis was identified in this cohort.ConclusionsOur data indicate that osteoporosis will develop in less than 10 % of female RA patients during rescreening intervals of approximately 9 years for those with normal bone density at baseline, 7 years for those with mild osteopenia, 4 years for those with moderate osteopenia, and 2 years for those with severe osteopenia at baseline. BMD interval in RA patients could be adjusted according to their baseline BMD T-scores.
28 schema:genre article
29 schema:inLanguage en
30 schema:isAccessibleForFree false
31 schema:isPartOf N48798d858d2e4570916b8d060445b2fe
32 N56c5d75a9e484d9d8d2591dcd5d5317a
33 sg:journal.1100834
34 schema:keywords BMD
35 BMD T
36 BMD interval
37 BMD test
38 BMD testing
39 BMD testing interval
40 Bone-density testing interval
41 ConclusionsOur data
42 IntroductionAlthough BMD testing
43 MethodsWe
44 RA
45 RA patients
46 ResultsAt baseline
47 age
48 analysis
49 arthritis
50 baseline
51 baseline BMD T
52 bone density
53 bone mineral density testing
54 cohort
55 competing-risk analysis
56 consecutive female patients
57 data
58 density
59 density testing
60 duration
61 estimated BMD testing interval
62 factors
63 female RA patients
64 female patients
65 group
66 intervals
67 mean age
68 menopausal status
69 mild osteopenia
70 mineral density (BMD) testing
71 moderate osteopenia
72 normal BMD
73 normal bone density
74 osteopenia
75 osteoporosis
76 participants
77 patients
78 proportion
79 range
80 rate
81 rate of transition
82 rheumatoid arthritis
83 risk factors
84 score range
85 scores
86 sensitivity analysis
87 severe osteopenia
88 significant risk factors
89 status
90 study
91 study participants
92 subgroups
93 test
94 testing
95 testing intervals
96 time
97 transition
98 years
99 schema:name Bone-density testing interval and transition to osteoporosis in patients with rheumatoid arthritis
100 schema:pagination 231-237
101 schema:productId N099f2afba03b4ba886ccc56af83359cb
102 Nc3160b4a55494c119bf379f74ac7fbe6
103 Ncc16700d396b40f6b1ddd4ec0f98c350
104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022991236
105 https://doi.org/10.1007/s00198-016-3703-7
106 schema:sdDatePublished 2021-11-01T18:28
107 schema:sdLicense https://scigraph.springernature.com/explorer/license/
108 schema:sdPublisher Nb7190470db90454db99c028c5e453996
109 schema:url https://doi.org/10.1007/s00198-016-3703-7
110 sgo:license sg:explorer/license/
111 sgo:sdDataset articles
112 rdf:type schema:ScholarlyArticle
113 N099f2afba03b4ba886ccc56af83359cb schema:name doi
114 schema:value 10.1007/s00198-016-3703-7
115 rdf:type schema:PropertyValue
116 N0aac0bd0e70049dd96404c6f2b4bacda schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Female
118 rdf:type schema:DefinedTerm
119 N1ab64cd21f9c4154b920096bb01dcb4d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Absorptiometry, Photon
121 rdf:type schema:DefinedTerm
122 N1df2c80780394828a509479dc0a67118 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Risk Assessment
124 rdf:type schema:DefinedTerm
125 N41d7469c50814b62ae5a7f8da5f7510c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Bone Diseases, Metabolic
127 rdf:type schema:DefinedTerm
128 N48798d858d2e4570916b8d060445b2fe schema:issueNumber 1
129 rdf:type schema:PublicationIssue
130 N4b038adc172f42ebb4f8c1e3c593e60c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Disease Progression
132 rdf:type schema:DefinedTerm
133 N4d3c558884cd40fe9332e6919d016cec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Humans
135 rdf:type schema:DefinedTerm
136 N5047213a405448b9bd043051f8e2e07f rdf:first sg:person.01143324620.76
137 rdf:rest N9f95b4bd8d7b42dabf4b3983a8061ead
138 N52bab588111c4b4fb897bcaaf8fb8712 rdf:first sg:person.011106215224.30
139 rdf:rest rdf:nil
140 N56c5d75a9e484d9d8d2591dcd5d5317a schema:volumeNumber 28
141 rdf:type schema:PublicationVolume
142 N7a2f9b5f7f0844c5bc3443ee12a97b97 rdf:first sg:person.01045430556.10
143 rdf:rest Nb1c533b7bc8a4fef941698a083245a84
144 N85c313263c7f4b08820e8b314d2404aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Aged
146 rdf:type schema:DefinedTerm
147 N86bd08aee8fa446d97829d1ab97dfe20 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Middle Aged
149 rdf:type schema:DefinedTerm
150 N9f95b4bd8d7b42dabf4b3983a8061ead rdf:first sg:person.0743465725.23
151 rdf:rest N7a2f9b5f7f0844c5bc3443ee12a97b97
152 Nb1c533b7bc8a4fef941698a083245a84 rdf:first sg:person.01312643345.06
153 rdf:rest N52bab588111c4b4fb897bcaaf8fb8712
154 Nb41eb2944e874d0e9f5a23a83ee90769 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Arthritis, Rheumatoid
156 rdf:type schema:DefinedTerm
157 Nb7190470db90454db99c028c5e453996 schema:name Springer Nature - SN SciGraph project
158 rdf:type schema:Organization
159 Nc3160b4a55494c119bf379f74ac7fbe6 schema:name dimensions_id
160 schema:value pub.1022991236
161 rdf:type schema:PropertyValue
162 Nc52a8a37cdad4f22be1ff7126d761105 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Mass Screening
164 rdf:type schema:DefinedTerm
165 Ncc16700d396b40f6b1ddd4ec0f98c350 schema:name pubmed_id
166 schema:value 27509834
167 rdf:type schema:PropertyValue
168 Nddb690d4a60f41f4a471e5b81c4243f1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Follow-Up Studies
170 rdf:type schema:DefinedTerm
171 Ne69abc77a6fd44558b4c53e22abca7da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Osteoporosis
173 rdf:type schema:DefinedTerm
174 Nee16bf11db784314ba9509cefb339047 rdf:first sg:person.01166345411.20
175 rdf:rest N5047213a405448b9bd043051f8e2e07f
176 Nf6205c25e8c34e229d3c7d4cebb47049 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Adult
178 rdf:type schema:DefinedTerm
179 Nf8bd5532e60f400a80863f70b46f75c7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Retrospective Studies
181 rdf:type schema:DefinedTerm
182 Nfacbf04761184e979ec83817a7f56369 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Bone Density
184 rdf:type schema:DefinedTerm
185 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
186 schema:name Medical and Health Sciences
187 rdf:type schema:DefinedTerm
188 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
189 schema:name Clinical Sciences
190 rdf:type schema:DefinedTerm
191 sg:journal.1100834 schema:issn 0937-941X
192 1433-2965
193 schema:name Osteoporosis International
194 schema:publisher Springer Nature
195 rdf:type schema:Periodical
196 sg:person.01045430556.10 schema:affiliation grid-institutes:grid.414964.a
197 schema:familyName Cha
198 schema:givenName H.-S.
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01045430556.10
200 rdf:type schema:Person
201 sg:person.011106215224.30 schema:affiliation grid-institutes:grid.414964.a
202 schema:familyName Lee
203 schema:givenName J.
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011106215224.30
205 rdf:type schema:Person
206 sg:person.01143324620.76 schema:affiliation grid-institutes:grid.264381.a
207 schema:familyName Lee
208 schema:givenName E.-K.
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143324620.76
210 rdf:type schema:Person
211 sg:person.01166345411.20 schema:affiliation grid-institutes:grid.415671.0
212 schema:familyName Hwang
213 schema:givenName J.
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01166345411.20
215 rdf:type schema:Person
216 sg:person.01312643345.06 schema:affiliation grid-institutes:grid.414964.a
217 schema:familyName Koh
218 schema:givenName E.-M.
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01312643345.06
220 rdf:type schema:Person
221 sg:person.0743465725.23 schema:affiliation grid-institutes:grid.264381.a
222 schema:familyName Ahn
223 schema:givenName J. K.
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743465725.23
225 rdf:type schema:Person
226 sg:pub.10.1007/s00198-014-2794-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038754393
227 https://doi.org/10.1007/s00198-014-2794-2
228 rdf:type schema:CreativeWork
229 sg:pub.10.1007/s001980070080 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005068152
230 https://doi.org/10.1007/s001980070080
231 rdf:type schema:CreativeWork
232 sg:pub.10.1007/s00296-008-0804-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022170133
233 https://doi.org/10.1007/s00296-008-0804-4
234 rdf:type schema:CreativeWork
235 sg:pub.10.1007/s007740050038 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007538058
236 https://doi.org/10.1007/s007740050038
237 rdf:type schema:CreativeWork
238 sg:pub.10.1007/s10067-011-1762-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1049467027
239 https://doi.org/10.1007/s10067-011-1762-x
240 rdf:type schema:CreativeWork
241 sg:pub.10.1186/ar2961 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028976451
242 https://doi.org/10.1186/ar2961
243 rdf:type schema:CreativeWork
244 grid-institutes:grid.264381.a schema:alternateName Department of Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea
245 Pharmaceutical Policy & Outcomes Research, Sungkyunkwan University School of Pharmacy, Suwon, South Korea
246 schema:name Department of Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea
247 Pharmaceutical Policy & Outcomes Research, Sungkyunkwan University School of Pharmacy, Suwon, South Korea
248 rdf:type schema:Organization
249 grid-institutes:grid.414964.a schema:alternateName Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, 06351, Seoul, South Korea
250 schema:name Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, 06351, Seoul, South Korea
251 rdf:type schema:Organization
252 grid-institutes:grid.415671.0 schema:alternateName Department of Internal Medicine, National Police Hospital, Seoul, South Korea
253 schema:name Department of Internal Medicine, National Police Hospital, Seoul, South Korea
254 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...